Hospitals Hit with Readmission Penalties; Some of Those Not Hit Used Precision Medicine in Strategy
As CMS announces readmission penalties for nearly 2,600 hospitals, some hospitals and health systems are finding precision medicine and big data efforts to be a new strategy for reducing 30-day readmissions…
UCSF Steps Up Biobanking Program Efforts, Naming Its First Chief Biobank Officer
Analysts predict that the global tissue banking market will grow to nearly $3 billion by 2026. Health executives at UCSF have recognized this trend and are executing on plan to attract patients and funding, and ultimately improve outcomes…
Hospital CEOs: McKinsey says “Hospitals Are Dead. Long Live the Hospital”
Trends affecting hospitals and health systems worldwide are forcing them to alter how they are structured and how they deliver care. Here’s how precision medicine factors in…
Independent and Rural Hospitals Closing at Record Rates, Vulnerable Patients at Risk of Missing Out on Precision Medicine’s Potential
Studies by KHN, Navigant, and others report that independent rural hospitals are closing at record rates, leaving patients without critical nearby healthcare services, including precision medicine’s benefits…
Answer These Questions Before Embarking on a Precision Medicine Journey
Temple University All of Us lead investigators discuss the clinical and business reasons and community impact of joining the NIH precision medicine research project…
Do Multigene Panels Offer Cancer Patients, Payers More Value?
Daryl Pritchard, PhD, discusses the untapped potential of multi-gene panel sequencing and targeted therapies for patients with advanced cancer….
Why the Cleveland Clinic Uses Telegenetics, Chatbots to Address Genetic Cancer Risk
Charis Eng, MD, PhD, explains how the Cleveland Clinic is overcoming workforce challenges in clinical cancer genetics…
Bridging the Gap Between the Clinical Possibilities and Economics of Precision Medicine
From research and development to pricing and access, the discourse on precision medicine is expanding, reflecting the emergence of new and multiple ideas of precision medicine aims in relation to healthcare economics, payment models, and patient outcomes…
Considering Risks and Privacy in Genetic Medicine: Q&A with Dr. Paul S. Appelbaum
Paul S. Appelbaum, MD, provides deeper insights into risks, privacy, and safeguarding patients’ genetic information…
How Healthcare Organizations Can Drive Diversity in Genetic Research
Joshua C. Denny, MD, explains the importance of diverse genetic data in fueling precision-medicine breakthroughs…
The Case for Precision Medicine in Primary Care
Pioneer in precision prevention explains the shift to precision medicine in primary care, and the work of Sanford Imagenetics in creating precision medicine modules for physicians…
3 Steps to Make Precision Medicine Part of the Medical Culture
Walking the fine line between not being the biggest risk taker and not being the last adopter, hospitals that offer genetic testing can expect their market share to increase and their payer mix to improve, according to LSUHSC’s Miele…
Managing and Maximizing the Volumes of Data Coming from Genomic Analysis
Lori Anderson of XIFIN to share views on the current state of informatics in precision medicine as well as challenges and future trends for this field…
How to Get Payers and Providers on the Same Page with Genetic Testing Reimbursement
Michael Astion, MD, PhD, to share how the philosophy of the “two rights” can drive alignment and compromise among payers, providers, and patients…
The Essential Ingredients for Pushing Precision Medicine Forward
Mary Zutter, MD, to share Vanderbilt’s lessons learned in assembling resources, selecting disease targets, and engaging physicians in precision medicine pursuits…
3 Scientific Principles Leaders Can Apply to Genetic Medicine Adoption
Olivier Elemento, PhD, to share what whole exome sequencing, whole genome sequencing, and artificial intelligence will mean to medicine and patient care…
Illumina Seeks to Reduce Burdens of Adopting Precision Medicine
Phil Febbo, MD, CMO of sequencing company Illumina, to discuss what company is doing to make it easier for health systems to adopt next-generation sequencing…
Pharmacogenomics to Eventually Touch Every Patient, Everywhere, Expert Says
Mayo Clinic professor Richard Weinshilboum, MD, describes a near future in which preemptive gene sequencing becomes standard of care for safe and effective drug therapies…
Geisinger Health Seeks to Help Eliminate ‘Sick Care’ Nationally
It’s been a little more than a year since Geisinger launched its National Precision Health Initiative, a first-of-its kind unit designed to advance the promise of anticipatory medicine at Geisinger and at healthcare systems throughout the United States…
Geisinger Health and Sanford Health Ready to Offer Genetic Tests and Precision Medicine Services in Primary Care Clinics
Rapidly falling costs and the increasing clinical value of human genome sequencing and genetic testing is reaching the point where innovative hospitals and health networks are ready to offer these services to patients in family practice settings…